Journal of Neural Transmission

, Volume 120, Issue 4, pp 597–605 | Cite as

Acoustic evaluation of short-term effects of repetitive transcranial magnetic stimulation on motor aspects of speech in Parkinson’s disease

  • I. Eliasova
  • J. Mekyska
  • M. Kostalova
  • R. Marecek
  • Z. Smekal
  • I. Rektorova
Neurology and Preclinical Neurological Studies - Original Article

Abstract

Hypokinetic dysarthria in Parkinson’s disease (PD) can be characterized by monotony of pitch and loudness, reduced stress, variable rate, imprecise consonants, and a breathy and harsh voice. Using acoustic analysis, we studied the effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) applied over the primary orofacial sensorimotor area (SM1) and the left dorsolateral prefrontal cortex (DLPFC) on motor aspects of voiced speech in PD. Twelve non-depressed and non-demented men with PD (mean age 64.58 ± 8.04 years, mean PD duration 10.75 ± 7.48 years) and 21 healthy age-matched men (a control group, mean age 64 ± 8.55 years) participated in the speech study. The PD patients underwent two sessions of 10 Hz rTMS over the dominant hemisphere with 2,250 stimuli/day in a random order: (1) over the SM1; (2) over the left DLPFC in the “on” motor state. Speech examination comprised the perceptual rating of global speech performance and an acoustic analysis based upon a standardized speech task. The Mann–Whitney U test was used to compare acoustic speech variables between controls and PD patients. The Wilcoxon test was used to compare data prior to and after each stimulation in the PD group. rTMS applied over the left SM1 was associated with a significant increase in harmonic-to-noise ratio and net speech rate in the sentence tasks. With respect to the vowel task results, increased median values and range of Teager-Kaiser energy operator, increased vowel space area, and significant jitter decrease were observed after the left SM1 stimulation. rTMS over the left DLPFC did not induce any significant effects. The positive results of acoustic analysis were not reflected in a subjective rating of speech performance quality as assessed by a speech therapist. Our pilot results indicate that one session of rTMS applied over the SM1 may lead to measurable improvement in voice quality and intensity and an increase in speech rate and tongue movements. Nevertheless, these changes were not accompanied by changes in a perceptual evaluation of speech performance by a speech therapist. Future placebo-controlled studies in larger patient cohorts should verify if rTMS would be clinically useful for treating hypokinetic dysarthria in PD.

Keywords

Hypokinetic dysarthria Parkinson’s disease rTMS Acoustic evaluation 

References

  1. Barrett J, Della-Maggiore V, Chouinard PA, Paus T (2004) Mechanisms of action underlying the effect of repetitive transcranial magnetic stimulation on mood: behavioral and brain imaging studies. Neuropharmacology 29:1172–1189Google Scholar
  2. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRefGoogle Scholar
  3. Beck AT, Steer RA, Brown GK (1996) Manual for the beck depression inventory-2. Psychological Corporation, San Antonio, TXGoogle Scholar
  4. Boersma P, Weenink D (2012) Praat: doing phonetics by computer (Version 5.3.23) http://www.praat.org/. Accessed 27 August 2012
  5. Boggio PS, Fregni F, Bermpohl F, Mansur CG, Rosa M, Rumi DO, Barbosa ER, Odebrecht Rosa M, Pascual-Leone A, Rigonatti SP, Marcolin MA, Araujo Silva MT (2005) Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson’s disease and concurrent depression. Mov Disord 20(9):1178–1184PubMedCrossRefGoogle Scholar
  6. Calzavara R, Mailly P, Haber SN (2007) Relationship between the corticostriatal terminals from areas 9 and 46, and those from area 8A, dorsal and rostral premotor cortex and area 24c: an anatomical substrate for cognition to action. Eur J Neurosci 26(7):2005–2024PubMedCrossRefGoogle Scholar
  7. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, MacPhee G, MacMahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AHV (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an International Pilot Study. Mov Disord 22(13):1901–1911PubMedCrossRefGoogle Scholar
  8. Cho SS, Strafella AP (2009) rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex. PLoS One 4(8):e6725PubMedCrossRefGoogle Scholar
  9. D'Alatri L, Paludetti G, Contarino FM, Galla S, Marchese MR, Bentivoglio AR (2008) Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice 22(3):365–372PubMedCrossRefGoogle Scholar
  10. Daniels N, Oates J, Phyland D, Feiglin A, Hughes A (1996) Vocal characteristics and response to levodopa in Parkinson’s disease. Mov Disord 11(Suppl. 1):117Google Scholar
  11. De Letter M, Santens P, Borsel JV (2005) The effects of levodopa on world intelligibility in Parkinson’s disease. J Commun Disord 38(3):187–196PubMedCrossRefGoogle Scholar
  12. Dell’osso B, Camuri G, Castellano F, Vecchi V, Benedetti M, Bortolussi S, Altamura AC (2011) Meta-review of metanalytic studies with repetitive transcranial magnetic stimulation (rTMS) for the treatment of major depression. Clin Pract Epidemiol Ment Health 7:167–177PubMedCrossRefGoogle Scholar
  13. Dias AE, Barbosa ER, Coracini KK, Maia FF, Marcolin MA, Fregni F (2006) Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson’s disease. Acta Neurol Scand 113:92–99PubMedCrossRefGoogle Scholar
  14. Dimitriadis D, Potamianos A, Maragos P (2009) A comparison of the squared energy and Teager-Kaiser operators for short-term energy estimation in additive noise. IEEE T Signal Process 57:2569–2581CrossRefGoogle Scholar
  15. Elahi B, Elahi B, Chen R (2009) Effect of transcranial magnetic stimulation on Parkinson motor function: systematic review of controlled clinical trials. Mov Disord 24(3):357–363PubMedCrossRefGoogle Scholar
  16. Fahn S, Elton RL, UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease. Macmillan, Florham Park, pp 153–163Google Scholar
  17. Folstein MF, Folstein SE, McHugh PR (1975) “Mini mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198PubMedCrossRefGoogle Scholar
  18. Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn SD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170PubMedCrossRefGoogle Scholar
  19. Goberman AM, Elmer LW (2005) Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease. J Commun Disord 38:215–230PubMedCrossRefGoogle Scholar
  20. Guse B, Falkai P, Wobrock T (2010) Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm 117(1):105–122PubMedCrossRefGoogle Scholar
  21. Hartelius L, Svantensson P, Hedlund A, Holmberg B, Revesz D, Thorlin T (2010) Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson’s disease. Folia Phoniatr Logop 62:104–109PubMedCrossRefGoogle Scholar
  22. Jankovic J, McDermott M, Carter J, Gauthier S, Goetz C, Goelbe L, Huber S, Koller W, Olanov C, Shoulson I, Stern M, Tanner C, W. Weiner W, and Parkinson Study Group (1990) Variable expression of Parkinson’s disease: a baseline analysis of the DAT ATOP cohort. Neurology 40:1529–1534CrossRefGoogle Scholar
  23. Larson KK, Ramig LO, Scherer RC (1994) Acoustic and glottographic voice analysis during drug-related fluctuations in Parkinson’s disease. J Med Speech Lang Pathol 2:227–239Google Scholar
  24. Lee JY, Kim JW, Lee WY, Kim JM, Ahn TB, Kim HJ, Cho J, Jeon BS (2010) Daily dose of dopaminergic medications in Parkinson disease: clinical correlates and a posteriori equation. Neurology Asia 15(2):137–143Google Scholar
  25. Leh SE, Petrides M, Strafella AP (2010) The neural circuitry of executive function in healthy subjects and Parkinson’s disease. Neuropsychopharmacol Rev 35:70–85CrossRefGoogle Scholar
  26. Limousin P, Krack P, Pollack P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL (1998) Stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 339:1105–1111PubMedCrossRefGoogle Scholar
  27. Michaelis D, Gramss T, Strube HW (1997) Glottal-to-noise excitation ratio—a new measure for describing pathological voices. Acta Acustica 83:700–706Google Scholar
  28. Murdoch BE (1998) Dysarthria: a physiological approach to assessment and treatment. Nelson Thornes, CheltenhamGoogle Scholar
  29. Murdoch BE, Ng ML, Barwood CHS (2012) Treatment of articulatory dysfunction in Parkinson’s disease using repetitive transcranial magnetic stimulation. Eur J Neurol 19(2):340–347PubMedCrossRefGoogle Scholar
  30. Narayana S, Fox PT, Zhang W, Franclin C, Robin DA, Vogel D, Ramig LO (2010) Neural correlates of efficacy of voice therapy in Parkinson’s disease identified by performance-correlation analysis. Hum Brain Mapp 31:222–236PubMedGoogle Scholar
  31. Pal E, Nagy F, Aschermann Z, Balazs E, Kovacs N (2010) The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson’s disease: a randomized, double-blind, placebo-controlled study. Mov Disord 25(14):2311–2317PubMedCrossRefGoogle Scholar
  32. Parent A (1990) Extrinsic connections of the basal ganglia. Trends Neurosci 13:254–258PubMedCrossRefGoogle Scholar
  33. Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 20(1):91–127PubMedCrossRefGoogle Scholar
  34. Petrides M, Pandya DN (1999) Dorsolateral prefrontal cortex: comparative cytoarchitectonic analysis in the human and the macaque brain and corticocortical connection patterns. Eur J Neurosci 11:1011–1036PubMedCrossRefGoogle Scholar
  35. Petrides M, Alivisatos B, Meyer E, Evans AC (1993) Functional activation of the human frontal cortex during the performance of verbal working memory task. Proc Natl Acad Sci USA 90:878–882PubMedCrossRefGoogle Scholar
  36. Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P (2004) Treatments for dysarthria in Parkinson’s disease. Lancet Neurol 3:547–556PubMedCrossRefGoogle Scholar
  37. Poluha PC, Teulings HL, Brookshire RH (1998) Handwriting and speech changes across the levodopa cycle in Parkinson’s disease. Acta Psychologica (Amst.) 100(1–2):71–84CrossRefGoogle Scholar
  38. Ramig LO, Sapir S, Countryman S, Pawlas AA, O’Brien C, Hoehn M, Thompson LL (2001) Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: a 2 year follow up. J Neurol Neurosurg Psychiatry 71:493–498PubMedCrossRefGoogle Scholar
  39. Ramig LO, Fox C, Sapir S (2008) Speech treatment for Parkinson’s disease. Expert Rev Neurother 8(2):297–309PubMedCrossRefGoogle Scholar
  40. Rektorova I, Megova S, Bares M, Rektor I (2005) Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients. J Neurol Sci 229–230:157–161PubMedCrossRefGoogle Scholar
  41. Rektorova I, Barrett J, Mikl M, Rektor I, Paus T (2007a) Functional abnormalities in the primary orofacial sensorimotor cortex during speech in Parkinson’s disease. Mov Disord 22(14):2043–2051PubMedCrossRefGoogle Scholar
  42. Rektorova I, Sedlackova S, Megova S, Hlubocky A, Rektor I (2007b) Repetitive transcranial magnetic stimulation for freezing of gait (FOG) in Parkinson’s disease. Mov Disord 22:1518–1519PubMedCrossRefGoogle Scholar
  43. Roubickova J, Hedanek J, Stranik A (2011) Dysarthric profile. Galen, PrahaGoogle Scholar
  44. Rousseaux M, Krystkowiak P, Kozlowski O, Ozsancak C, Blond S, Destee A (2004) Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility. J Neurol 251:327–334PubMedCrossRefGoogle Scholar
  45. Rusz J, Cmejla R, Ruzickova H, Klempir J, Majerova V, Picmausova J, Roth J, Ruzicka E (2012) Evaluation of speech impairment in early stages of Parkinson’s disease: a prospective study with the role of pharmacotherapy. J Neural Transm. doi:10.1007/s00702-012-0853-4 PubMedGoogle Scholar
  46. Sapir S, Ramig LO, Spielman JL, Fox C (2010) Formant centralization ratio (FCR): a proposal for a new acoustic measure of dysarthric speech. J Speech Lang Hear Res 53(1):114. doi:10.1044/1092-4388(2009/08-0184 PubMedCrossRefGoogle Scholar
  47. Sedlácková S, Rektorová I, Srovnalová H, Rektor I (2009) Effect of high frequency repetitive transcranial magnetic stimulation on reaction time, clinical features and cognitive functions in patients with Parkinson’s disease. J Neural Transm 116(9):1093–1101PubMedCrossRefGoogle Scholar
  48. Siebner HR, Rothwell J (2003) Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res 148(1):1–16PubMedCrossRefGoogle Scholar
  49. Skodda S, Visser W, Schlegel U (2010) Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease. J Neural Transm 117:197–205PubMedCrossRefGoogle Scholar
  50. Solomon NP, Hixon TJ (1993) Speech breathing in Parkinson’s disease. J Speech Hear Res 36:294–310PubMedGoogle Scholar
  51. Stiasny-Kolster K, Mayer G, Schäfer S, Möller JC, Heinzel-Gutenbrunner M, Oertel WH (2007) The REM sleep behavior disorder screening questionnaire—A new diagnostic instrument. Mov Disord 22(16):2386–2393PubMedCrossRefGoogle Scholar
  52. Strafella AP, Paus T, Barrett J, Dagher A (2001) Repetitive transcranial magnetic stimulation of the human prefrontal cortex induced dopamine release in the caudate nucleus. J Neurosci 21:RC157PubMedGoogle Scholar
  53. Ward CD, Gibb WR (1990) Research diagnostic criteria for Parkinson’s disease. Adv Neurol 53:245–249PubMedGoogle Scholar

Copyright information

© Springer-Verlag Wien 2012

Authors and Affiliations

  • I. Eliasova
    • 1
    • 2
  • J. Mekyska
    • 3
    • 4
  • M. Kostalova
    • 2
    • 5
  • R. Marecek
    • 1
    • 2
  • Z. Smekal
    • 3
    • 4
  • I. Rektorova
    • 1
    • 2
  1. 1.First Department of Neurology, Faculty of MedicineSt. Anne’s University Hospital and CEITEC MUBrnoCzech Republic
  2. 2.Applied Neurosciences Research Group, Central European Institute of Technology, CEITECMUBrnoCzech Republic
  3. 3.Signal Processing Laboratory, Department of Telecommunications, Faculty of Electrical Engineering and CommunicationBrno University of TechnologyBrnoCzech Republic
  4. 4.SIX Research Centre, Faculty of Electrical Engineering and CommunicationBrno University of TechnologyBrnoCzech Republic
  5. 5.Second Department of NeurologyFaculty Hospital and Masaryk UniversityBrnoCzech Republic

Personalised recommendations